🔎 Trials Near Me

Home › Kanser sa Dibdib › Florida

Pag-aaral pangklinika para sa Kanser sa Dibdib sa Florida

6 pag-aaral para sa Kanser sa Dibdib ang naghahanap ng mga kalahok sa mga site sa Florida.

Opisyal na teksto ng pag-aaral (English)

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Florida Cancer Specialists, Sarasota
  • Moffitt Cancer Center and Research Institute, Tampa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

  • Site 1009, Plantation
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07407933

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Millennium Oncology Research Clinic, Hollywood
  • University of Florida - Jacksonville, Jacksonville
  • Miami Cancer Institute at Baptist Health, Inc., Miami
  • at 3 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • Memorial Healthcare System, Hollywood
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Moffitt Cancer Center, Tampa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines
  • Miami VA Healthcare System, Miami, FL, Miami
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 19, 2026 · NCT02984761

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.